JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M909080199 on April 3, 2000

J. Biol. Chem., Vol. 275, Issue 22, 16450-16458, June 2, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/16450    most recent
M909080199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukhina, S.
Right arrow Articles by Tkachuk, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukhina, S.
Right arrow Articles by Tkachuk, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain
CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO CHEMOTAXIS*

Svetlana MukhinaDagger , Victoria Stepanova§, Dmitri Traktouev, Alexei Poliakov, Robert Beabealashvilly, Yaroslav Gursky, Mikhail Minashkin, Alexander Shevelev, and Vsevolod Tkachuk

From the Institute of Experimental Cardiology, Cardiology Research Center, Moscow 121552, Russia

Urokinase plasminogen activator (uPA) is thought to exert its effects on cell growth, adhesion, and migration by mechanisms involving proteolysis and interaction with its cell surface receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activity were analyzed using human airway smooth muscle cells (hAWSMC). The wild-type uPA (r-uPAwt), inactive urokinase with single mutation (His204 to Gln) (r-uPAH/Q), urokinase with mutation of His204 to Gln together with a deletion of growth factor-like domain (r-uPAH/Q-GFD), the catalytic domain of urokinase (r-uPALMW), and its kringle domain (r-KD) were expressed in Escherichia coli. We demonstrate that glycosylated uPA, r-uPAwt, r-uPAH/Q, and r-uPAH/Q-GFD elicited similar chemotactic effects. Half-maximal chemotaxis (EC50) were apparent at approximately 2 nM with all the uPA variants. The kringle domain induced cell migration with an EC50 of about 6 nM, whereas the denaturated r-KD and r-uPALMW were without effect. R-uPAwt-induced chemotaxis was dependent on an association with uPAR and a uPA-kringle domain-binding site, determined using a monoclonal uPAR antibody to prevent the uPA-uPAR interaction, and a monoclonal antibody to the uPA-kringle domain. The binding of iodinated r-uPAwt with hAWSMC was due to interaction with a high affinity binding site on the uPAR, and a lower affinity binding site on an unidentified cell surface target, which was mediated exclusively through the kringle domain of urokinase. Specific binding of r-uPAH/Q-GFD to hAWSMC involved an interaction with a single site whose characteristics were similar to those of the low affinity site of r-uPAwt binding to hAWSMC. uPAR-deficient HEK 293 cells specifically bound r-uPAwt and r-uPAH/Q-GFD via a single, similar type of binding site. These cells migrated when stimulated by r-uPAH/Q-GFD and uPAwt, but not r-uPALMW. HEK 293 cells transfected with the uPAR cDNA expressed two classes of sites that bound r-uPAwt; however, only a single site was responsible for the binding of r-uPAH/Q-GFD. Together, these findings indicate that uPA-induced chemotaxis is dependent on the binding of the uPA-kringle to the membrane surface of cells and the association of uPA with uPAR.


* This work was supported by Russian Fundamental Research Foundation Grants 96-04-50714 and 00-04-48699.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Partial fulfilment of a PhD degree.

§ To whom correspondence should be addressed: Molecular Endocrinology Laboratory, Inst. of Experimental Cardiology, Cardiology Research Center, Cherepkovskaya St., 15, Moscow 121552, Russia. Tel.: 7-095-414-67-13; Fax: 7-095-414-67-12; E-mail: V.Stepanova@cardio.ru.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al.
Nuclear translocation of urokinase-type plasminogen activator
Blood, July 1, 2008; 112(1): 100 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Hirakawa, Y. Karashima, M. Watanabe, C. Kimura, Y. Ito, and M. Oike
Protein Kinase A Inhibits Lysophosphatidic Acid-Induced Migration of Airway Smooth Muscle Cells
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1102 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. Govindaraju, M.-C. Michoud, M. Al-Chalabi, P. Ferraro, W. S. Powell, and J. G. Martin
Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C957 - C965.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Q. Wang, K. Bdeir, S. Yarovoi, D. B. Cines, W. Fang, and E. Abraham
Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury
J. Immunol., October 15, 2006; 177(8): 5550 - 5557.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Chest, September 1, 2006; 130(3): 741 - 753.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Franco, I. Vocca, M. V. Carriero, D. Alfano, L. Cito, I. Longanesi-Cattani, P. Grieco, L. Ossowski, and M. P. Stoppelli
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and {alpha}v{beta}5 integrin
J. Cell Sci., August 15, 2006; 119(16): 3424 - 3434.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham
The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins
J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. V. Ustach and H.-R. C. Kim
Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells
Mol. Cell. Biol., July 15, 2005; 25(14): 6279 - 6288.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. K. Jeffery
Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. M. Bernstein, R. S. Greenberg, L. Taliana, and S. K. Masur
Urokinase Anchors uPAR to the Actin Cytoskeleton
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2967 - 2977.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Puig-de-Morales, E. Millet, B. Fabry, D. Navajas, N. Wang, J. P. Butler, and J. J. Fredberg
Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C643 - C654.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Zhang, X. Cai, J. M. Lopez-Guisa, S. J. Collins, and A. A. Eddy
Mitogenic Signaling of Urokinase Receptor-Deficient Kidney Fibroblasts: Actions of an Alternative Urokinase Receptor and LDL Receptor-Related Protein
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2090 - 2102.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Das, G. H. Mahabeleshwar, and G. C. Kundu
Osteopontin Induces AP-1-mediated Secretion of Urokinase-type Plasminogen Activator through c-Src-dependent Epidermal Growth Factor Receptor Transactivation in Breast Cancer Cells
J. Biol. Chem., March 19, 2004; 279(12): 11051 - 11064.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines
The kringle stabilizes urokinase binding to the urokinase receptor
Blood, November 15, 2003; 102(10): 3600 - 3608.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Das, G. H. Mahabeleshwar, and G. C. Kundu
Osteopontin Stimulates Cell Motility and Nuclear Factor {kappa}B-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells
J. Biol. Chem., August 1, 2003; 278(31): 28593 - 28606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. M. Madison
Migration of Airway Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 8 - 11.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E. Abraham, M. R. Gyetko, K. Kuhn, J. Arcaroli, D. Strassheim, J. S. Park, S. Shetty, and S. Idell
Urokinase-Type Plasminogen Activator Potentiates Lipopolysaccharide-Induced Neutrophil Activation
J. Immunol., June 1, 2003; 170(11): 5644 - 5651.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. M. Carlin, M. Roth, and J. L. Black
Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1020 - L1026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Shetty, K. Bdeir, D. B. Cines, and S. Idell
Induction of Plasminogen Activator Inhibitor-1 by Urokinase in Lung Epithelial Cells
J. Biol. Chem., May 9, 2003; 278(20): 18124 - 18131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Kim, Y.-K. Hong, Y. A. Joe, Y. Lee, J.-Y. Shin, H.-E. Park, I.-H. Lee, S.-Y. Lee, D.-K. Kang, S.-I. Chang, et al.
Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells
J. Biol. Chem., March 21, 2003; 278(13): 11449 - 11456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Netzel-Arnett, D. J. Mitola, S. S. Yamada, K. Chrysovergis, K. Holmbeck, H. Birkedal-Hansen, and T. H. Bugge
Collagen Dissolution by Keratinocytes Requires Cell Surface Plasminogen Activation and Matrix Metalloproteinase Activity
J. Biol. Chem., November 15, 2002; 277(47): 45154 - 45161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sidenius, A. Andolfo, R. Fesce, and F. Blasi
Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization
J. Biol. Chem., July 26, 2002; 277(31): 27982 - 27990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Sliva, M. T. Rizzo, and D. English
Phosphatidylinositol 3-Kinase and NF-kappa B Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator
J. Biol. Chem., January 25, 2002; 277(5): 3150 - 3157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon
Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations
Am. J. Pathol., January 1, 2002; 160(1): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Page, A. J. Ammit, J. L. Black, and C. L. Armour
Human mast cell and airway smooth muscle cell interactions: implications for asthma
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. K. JEFFERY
Remodeling in Asthma and Chronic Obstructive Lung Disease
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S28 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. L. BLACK, M. ROTH, J. LEE, S. CARLIN, and P. R. A. JOHNSON
Mechanisms of Airway Remodeling . Airway Smooth Muscle
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S63 - 66.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.